| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | BRD-K51831558 | CTRPv2 | pan-cancer | AAC | 0.0084 | 0.9 |
| mRNA | YM-155 | CTRPv2 | pan-cancer | AAC | -0.0058 | 0.9 |
| mRNA | Nutlin-3 | CTRPv2 | pan-cancer | AAC | -0.0053 | 0.9 |
| mRNA | CIL56 | CTRPv2 | pan-cancer | AAC | 0.0071 | 0.9 |
| mRNA | Erlotinib | gCSI | pan-cancer | AAC | 0.0086 | 0.9 |
| mRNA | BRD-K96970199 | CTRPv2 | pan-cancer | AAC | 0.011 | 0.9 |
| mRNA | Tamoxifen | GDSC1000 | pan-cancer | AAC | 0.0051 | 0.9 |
| mRNA | OSI-027 | GDSC1000 | pan-cancer | AAC | 0.0046 | 0.9 |
| mRNA | pitstop2 | CTRPv2 | pan-cancer | AAC | -0.0063 | 0.9 |
| mRNA | IOX2 | GDSC1000 | pan-cancer | AAC | -0.0048 | 0.9 |